Geneva-based drug development company Novlmmune has announced the closing of a Series B private financing round. New investor BZ Bank led the SFR 58m financing round. Pictet Private Equity Investors SA as well as previous investors Lombard Odier Darier Hentsch, Novartis Venture Fund and Aravis Venture also participated.
Company has so far added on three companies and used its cashflow to acquire them
Responsible & Sustainable Corporate Turnaround Fund intends to support the recovery of Italian companies
Sale ends a three-year holding period for the GP, which invested in the company via its seventh fund
Ireland-based enterprise procurement software company is also backed by Paua Ventures